Catalyst Wire Dossier Catalyst Wire Dossier

Eplerenone (generic)

Eplerenone · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eplerenone (generic), covering 2008-01-31 to 2017-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions [Phase 1]

See pricing